Cargando…
Myoferlin silencing inhibits VEGFR2-mediated proliferation of metastatic clear cell renal cell carcinoma
Recently, ramucirumab, a drug that targets vascular endothelial growth factor receptor (VEGFR), was clinically approved; therefore, we evaluated VEGFR2 expression and its predictive roles in tumor progression in clear cell renal cell carcinoma (CCRCC). Since we do not have many options for treating...
Autores principales: | An, Hyo Jung, Song, Dae Hyun, Koh, Hyun Min, Kim, Yu-Min, Ko, Gyung Hyuck, Lee, Jeong-Hee, Lee, Jong Sil, Yang, Jung Wook, Kim, Min Hye, Seo, Deok Ha, Jang, Se Min, Kim, Dong Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718427/ https://www.ncbi.nlm.nih.gov/pubmed/31477752 http://dx.doi.org/10.1038/s41598-019-48968-7 |
Ejemplares similares
-
Prognostic role of myoferlin expression in patients with clear cell renal cell carcinoma
por: Song, Dae Hyun, et al.
Publicado: (2017) -
Myoferlin expression in non-small cell lung cancer: Prognostic role and correlation with VEGFR-2 expression
por: SONG, DAE HYUN, et al.
Publicado: (2016) -
Myoferlin Expression and Its Correlation with FIGO Histologic Grading in Early-Stage Endometrioid Carcinoma
por: Kim, Min Hye, et al.
Publicado: (2018) -
Correlation between myoferlin expression and lymph node metastasis in papillary thyroid carcinoma
por: Na, Ji Min, et al.
Publicado: (2022) -
Prognostic role of S100A9 expression in patients with clear cell renal cell carcinoma
por: Koh, Hyun Min, et al.
Publicado: (2019)